Lopedota A, Cutrignelli A, Trapani A, Boghetich G, Denora N, Laquintana V, Trapani G, Liso G
Facoltà di Farmacia, Dipartimento Farmaco-Chimico, Università degli Studi di Bari, Via Orabona 4, 70125 Bari, Italy.
J Microencapsul. 2007 May;24(3):214-24. doi: 10.1080/02652040601058152.
The aim of this study was to gain insight into the feasibility of using microparticles (MPs) constituted by the biodegradable poly (DL-lactide-co-glycolide) (PLGA) and a number of cyclodextrins (CDs) as an orally sustained delivery system of the hypnotic agent etizolam (ETZ). A further aim of the work was to investigate the effects of different CDs on the morphology, loading, and release properties of the MPs prepared. For these purposes, ETZ alone, and ETZ/CD-PLGA loaded MPs were prepared by the W/O/W emulsion-solvent evaporation method. It was found that the release of ETZ in vitro was more prolonged over three days with a kinetic constant proportional to t(1/2). It was also demonstrated that the CDs in these MPs are able to modulate several properties such as morphology, drug loading, and release properties. In fact, marked differences in shape, surface, and encapsulation efficiencies were noted depending on the presence, hydrophilicity, and charge of the CD employed. The obtained results induce us to consider the present ETZ-containing formulations as new valuable tools for the treatment of different insomnia categories.
本研究的目的是深入了解使用由可生物降解的聚(DL-丙交酯-共-乙交酯)(PLGA)和多种环糊精(CDs)构成的微粒(MPs)作为催眠药依替唑仑(ETZ)口服缓释给药系统的可行性。该研究的另一个目的是研究不同的CDs对所制备MPs的形态、载药量和释放特性的影响。为了这些目的,通过W/O/W乳液-溶剂蒸发法制备了单独的ETZ以及负载ETZ/CD-PLGA的MPs。结果发现,ETZ在体外的释放持续超过三天,其动力学常数与t(1/2)成正比。还证明这些MPs中的CDs能够调节多种性质,如形态、载药量和释放特性。事实上,根据所用CD的存在、亲水性和电荷,在形状、表面和包封效率方面观察到显著差异。所获得的结果促使我们将目前含ETZ的制剂视为治疗不同类型失眠的新的有价值工具。